MPG.eBooks - Search Results - ("positivism" OR "positivity")

1

Pharmacoeconomic review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication: indicated in addition to standard therapy for reducing disease activity in adult patients...

Published 2020

CADTH

“..., autoantibody-positive SLE. This submission relates to belimumab subcutaneous (SC) injection, 200 mg/mL weekly...”

Read Now

2

Pharmacoeconomic review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication: indicated in addition to standard therapy for reducing disease activity in adult patients...

Published 2020

CADTH

“..., autoantibody-positive SLE. This submission relates to belimumab subcutaneous (SC) injection, 200 mg/mL weekly...”

Read Now

3

Clinical review report: Satralizumab (Enspryng) : (Hoffmann-La Roche Limited) : indication neuromyelitis optica spectrum disorder

Published 2021

Canadian Agency for Drugs and Technologies in Health

“... of NMOSD in adult and adolescent patients who are AQP4 antibody positive...”

Read Now

4

HPV RNA test for cervical cancer

by Sæterdal, Ingvil, Juvet, Lene K., Natvig Norderhaug, Inger
Published 2008

Norwegian Knowledge Centre for the Health Services

Read Now

5

Clinical review report: Eculizumab (Soliris) : Alexion Pharma Canada Corp. : indication: neuromyelitis optica spectrum disorder

Published 2020

Canadian Agency for Drugs and Technologies in Health

“... disorder in adult patients who are anti-aquaporin-4 antibody positive...”

Read Now

6

CADTH reimbursement recommendation: Satralizumab (Enspryng) : for the treatment of neuromyelitis optica spectrum disorder : recommendation : reimburse with conditions

Published 2021

Canadian Agency for Drugs and Technologies in Health

“... years and older, anti-AQP4 positive, have had at least 1 NMOSD relapse in the 12 months before...”

Read Now

7

Clinical review report: Eculizumab (Soliris) : Alexion Pharma Canada corporation : indication : adult patients with generalized myasthenia gravis

Published 2020

Canadian Agency for Drugs and Technologies in Health

“... effects of eculizumab for the treatment of adult patients who are AChR-antibody-positive and have...”

Read Now

8

General childhood vaccination against HPV 16 and 18 aimed at preventing cervical cancer

Published 2008

Swedish Council on Health Technology Assessment

“... that the public can accept regarding positive and negative effects when allocating resources....”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada Corp.) : indication : the treatment of neuromyelitis optica spectrum disorder (NMOS...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...-AQP4 antibody positive. Eculizumab is not intended for acute treatment of an NMOSD relapse. Eculizumab...”

Read Now

10

General childhood vaccination against HPV 16 and 18 aimed at preventing cervical cancer

Published 2008

Swedish Council on Health Technology Assessment

“... that the public can accept regarding positive and negative effects when allocating resources....”

Read Now

11

Pharmacoeconomic report: Eculizumab (Soliris) : Alexion Pharma Canada Corporation : indication : adult patients with generalized myasthenia gravis

Published 2020

Canadian Agency for Drugs and Technologies in Health

“... for patients with refractory AChR-antibody-positive generalized myasthenia gravis (gMG) at a willingness-to-pay...”

Narrow Search